Latest Insider Transactions at Humacyte, Inc. (HUMA)
This section provides a real-time view of insider transactions for Humacyte, Inc. (HUMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Humacyte, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Humacyte, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2022
|
Dale A. Sander CFO and Chief Corp. Deve. Off. |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$8,000
$4.53 P/Share
|
|
Dec 16
2021
|
Laura E Niklason President, CEO and Director |
SELL
Open market or private sale
|
Indirect |
75,000
-12.82%
|
$675,000
$9.0 P/Share
|
|
Dec 16
2021
|
Brady W Dougan Director |
SELL
Open market or private sale
|
Direct |
75,000
-12.82%
|
$675,000
$9.0 P/Share
|
|
Dec 15
2021
|
Laura E Niklason President, CEO and Director |
SELL
Open market or private sale
|
Indirect |
125,000
-17.6%
|
$1,000,000
$8.88 P/Share
|
|
Dec 15
2021
|
Brady W Dougan Director |
SELL
Open market or private sale
|
Direct |
125,000
-17.6%
|
$1,000,000
$8.88 P/Share
|
|
Dec 14
2021
|
Laura E Niklason President, CEO and Director |
SELL
Open market or private sale
|
Indirect |
100,000
-6.31%
|
$900,000
$9.56 P/Share
|
|
Dec 14
2021
|
Brady W Dougan Director |
SELL
Open market or private sale
|
Direct |
100,000
-6.31%
|
$900,000
$9.56 P/Share
|
|
Nov 22
2021
|
Michael T. Constantino Director |
BUY
Open market or private purchase
|
Direct |
2,500
+48.96%
|
$25,000
$10.81 P/Share
|
|
Aug 26
2021
|
William Edward Tente Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,519
+50.0%
|
-
|
|
Aug 26
2021
|
Heather Ledbetter Prichard Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+50.0%
|
-
|
|
Aug 26
2021
|
Jeffrey Harold Lawson Chief Surgical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,877
+50.0%
|
-
|
|
Aug 26
2021
|
Max N. Wallace Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,986
+50.0%
|
-
|
|
Aug 26
2021
|
Ayabudge LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Ayabudge LLC > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
18,930,004
+50.0%
|
-
|
|
Aug 26
2021
|
Brady W Dougan Director |
BUY
Open market or private purchase
|
Indirect |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Brady W Dougan Director |
BUY
Grant, award, or other acquisition
|
Indirect |
20,078,244
+50.0%
|
-
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Open market or private purchase
|
Indirect |
1,522,500
+6.93%
|
$15,225,000
$10.0 P/Share
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Grant, award, or other acquisition
|
Indirect |
18,930,004
+50.0%
|
-
|
|
Aug 26
2021
|
Laura E Niklason President, CEO and Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,148,240
+50.0%
|
-
|